LOGIN (VIA WILEY ONLINE LIBRARY)
Question:Is there randomized controlled trial evidence to support the use of homocysteine-lowering interventions for preventing cardiovascular events in adults at risk of, or with existing cardiovascular disease?
THIS CLINICAL ANSWER IS ARCHIVED
EXCERPT of full Clinical Answer
This Cochrane Clinical Answer evaluates the use of homocysteine-lowering interventions for preventing cardiovascular events in people at risk of, or with existing cardiovascular disease.
Browse Clinical Answers
- Allergy & intolerance
- Blood disorders
- Cancer
- Child health
- Complementary & alternative medicine
- Consumer & communication strategies
- Dentistry & oral health
- Developmental, psychosocial & learning problems
- Ear, nose & throat
- Effective practice & health systems
- Endocrine & metabolic
- Eyes & vision
- Fertility
- Gastroenterology & hepatology
- Genetic disorders
- Gynecology
- Health & safety at work
- Heart & circulation
- Infectious disease
- Kidney disease
- Lungs & airways
- Mental health
- Neonatal care
- Neurology
- Orthopedics & trauma
- Pain & anesthesia
- Pregnancy & childbirth
- Public health
- Rheumatology
- Skin disorders
- Tobacco, drugs & alcohol
- Urology
- Wounds